Veracyte has announced the launch of its non-invasive test to improve the diagnosis of interstitial lung diseases, including  idiopathic pulmonary fibrosis (IPF). The soon-to-be commercially available test, Envisia Genomic Classifier, is reported to offer a faster and more accurate diagnosis than is currently available without the need for a lung biopsy. Data…
Nutritious Sweet Potatoes Do you enjoy sweet potatoes? Did you know they’re a super food that contain many nutritional benefits? The World’s Healthiest Foods, list numerous benefits of incorporating sweet potatoes into your diet. Some of these health benefits include increasing your antioxidant intake, consuming more anti-inflammatory…
This Boehringer Ingelheim Idiopathic Pulmonary Fibrosis video explains high-resolution computerized tomography (HRCT) scans. While there is no known cause for idiopathic pulmonary fibrosis, there are some aspects which could be to blame. Find out more. This animated film explains why patients with pulmonary fibrosis would need an HRCT…
Patients with idiopathic pulmonary fibrosis (IPF) have a high risk of developing other health conditions, according to results of a study presented at the annual meeting of the American College of Chest Physicians (CHEST 2016), held in Los Angeles Oct. 22-26. The results were presented under the title “Longitudinal…
Sometimes it is hard to keep going when you have pulmonary fibrosis The basics of living life and traveling are now such a challenge for me … like breathing, walking, being tired, having to bring oxygen and needing help. I recently attended a Writer’s…
The effectiveness of long-term treatment with the anti fibrotic drug Esbriet (pirfenidone) for more than 3 years does not depend on the forced vital capacity (FVC) at baseline in patients with idiopathic pulmonary fibrosis (IPF), according to a clinical trial called RECAP (NCT00662038).
According to PulmonaryFibrosis.org, there are several types of treatment options to help you with your pulmonary fibrosis. In this article, we’re focusing on bringing you non-pharmacological pulmonary fibrosis treatments. 1. Do not smoke! If you’ve been diagnosed with pulmonary fibrosis or any other lung disease, smoking is…
Esbriet (pirfenidone) can be used as a long-term therapy in idiopathic pulmonary fibrosis (IPF) patients with more severe loss of lung function, according to results presented at the American College of Chest Physicians (CHEST 2016), held in Los Angeles from Oct. 22–26. The findings were described in the oral presentation, “…
In this University of Exeter video, Dr. Chris Scotton talks about his research in idiopathic pulmonary fibrosis in order to better understand the development of the disease, and to try to develop new model systems for drug testing. Discover why pulmonary fibrosis is so…
Results from two Phase 3 studies, known as the INPULSIS trials, further confirmed the efficacy of Ofev (nintedanib) to treat idiopathic pulmonary fibrosis (IPF) regardless of disease severity. The results, from post-hoc pooled analyses of the trials, were recently presented at the CHEST 2016 Annual Meeting, running in Los Angeles through Wednesday, Oct. 26.
Get regular updates to your inbox.
